Investing Ideas
/
U.K. Pharmaceuticals & Biotech High Return On Equity, Low Debt

U.K. Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

HUTCHMED (China)

Market Cap: UK£2.2b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

HCM

UK£2.60

11.3%

-0.8%